Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus

Details for Australian Patent Application No. 2008305294 (hide)

Owner Array Biopharma Inc.

Inventors Boyd, Steven Armen; Wallace, Eli M.; Fell, Jay Bradford; Gunawardana, Indrani W.; Hinklin, Ronald Jay; Aicher, Thomas Daniel; Fischer, John P.; Turner, Timothy M.; Singh, Ajay; Chicarelli, Mark Joseph; Condroski, Kevin Ronald

Agent Shelston IP

Pub. Number AU-A-2008305294

PCT Pub. Number WO2009/042435

Priority 60/974,225 21.09.07 US

Filing date 15 September 2008

Wipo publication date 2 April 2009

International Classifications

A61K 31/433 (2006.01) - Thiadiazoles

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

25 March 2010 PCT application entered the National Phase

  PCT publication WO2009/042435 Priority application(s): WO2009/042435

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008305303-Methods and compounds for treating retinol-related diseases

2008305288-Methods and apparatus having multiple separately actuatable expandable members